Speech-Language Pathologists in Olathe, KS Accepting Medicare

68 Speech-Language Pathologists found. Showing 1 - 20

Sincere Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13821 S Mullen St, Olathe, KS 66062 Phone: 913-669-5406

Laura K Green, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14188 W 150th Ct, Olathe, KS 66062 Phone: 913-829-7775    Fax: 913-829-7765

Encore Preakness, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13875 W 115th Ter, Smrs Office, Olathe, KS 66062 Phone: 913-906-0990

Stacy Rezek, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 128 S Chestnut St, Olathe, KS 66061 Phone: 913-488-3678

Mrs. Sarah E Ward, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4200

Molly Klein, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20911 W 153rd St, Olathe, KS 66061 Phone: 913-397-2900

Ms. Leslie A Caldwell, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 450 E Park St, Olathe, KS 66061 Phone: 913-324-0600

Allison Colleen Zande, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11680 S Rene Ct, Olathe, KS 66062 Phone: 913-961-9201

Ms. Colleen Dalton Delehanty Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1844 E 153rd Cir, Olathe, KS 66062 Phone: 913-787-6735

Danielle Comford Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13800 W 116th St, Olathe, KS 66062 Phone: 913-828-4180

Megan Wizniak Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14200 W 134th Pl, Olathe, KS 66062 Phone: 913-322-3111

Mrs. Paula Jean Crotty Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14340 S Twilight Ln, Olathe, KS 66062 Phone: 913-780-6110

Mrs. Laura Leigh Hermansen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 E Flaming Rd, Olathe, KS 66061 Phone: 913-829-2273

Anne Kathleen Wietharn, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21250 W 151st St, Olathe, KS 66061 Phone: 913-390-0444

Mrs. Mary Katherine Keenan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11574 Longview, Olathe, KS 66061 Phone: 913-638-9431

Lauren Jane-mirocke Harris Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 W 151st St # 913586, Olathe, KS 66061 Phone: 913-586-2763

Rose Padilla Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 E Flaming Rd, Olathe, KS 66061 Phone: 913-829-2273

Amanda Briones, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12814 S Blackfoot Dr, Olathe, KS 66062 Phone: 816-729-5213

Jennifer Sogas, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14188 W 150th Ct, Olathe, KS 66062 Phone: 913-829-7775    Fax: 913-829-7765

Hollie Elizabeth Porsi, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 E Flaming Rd, Olathe, KS 66061 Phone: 913-780-4844

News Archive

CPRIT awards Bellicum $5.7 million to advance CaspaCIDe therapy for late stage cancer

Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this second round of the commercialization award program.

CPEX Pharmaceuticals' Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

New research from the Cleveland Clinic shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

Study: More attention needs to be paid for cartilage during RA diagnosis

This could lead to a paradigm shift in the treatment of rheumatoid arthritis: rheumatologists at the Medical University of Vienna have discovered, through a secondary study involving 3,000 female patients, that the condition of the cartilage in inflammatory joint rheumatism needs to be paid more attention than has previously been the case. Until now, the focus lay mainly on investigating the damage to the bone.

Study: Individuals' diet influences gut microbial diversity

Scientists from The University of Texas at Austin and five other institutions have discovered that the more diverse the diet of a fish, the less diverse are the microbes living in its gut. If the effect is confirmed in humans, it could mean that the combinations of foods people eat can influence the diversity of their gut microbes.

Read more Medical News

› Verified 7 days ago

• 1(current)
• 2
• 3
• 4